Aurobindo Pharma Limited — JV/Acquisition, 01-10-2025: Acquisition

Aurobindo Pharma has completed an internal group restructuring. Its wholly-owned subsidiary, Curateq Biologics B.V., now holds the entire 100% stake in CuraTeQ Biologics s.r.o., acquired from fellow subsidiary Helix Healthcare B.V. This strategic move streamlines Aurobindo Pharma's internal operations by consolidating CuraTeQ Biologics directly under Curateq Biologics B.V. No deal value was specified as it’s an internal transfer, and this realignment is not expected to materially impact Aurobindo Pharma's consolidated financial results or operational performance.